RadNet Posts 30c Adjusted EPS for Third Quarter
RDNT sits 50% above its 52-week low of $50.82 on elevated volume (2.5× avg).
Summary
RadNet reported third-quarter adjusted EPS of 30 cents, per Dow Jones Newswires, and net income of $4.15M. The headline carries only the adjusted EPS line, with no revenue, EBITDA, or guidance figures, so the print cannot be judged against the record Q2 revenue of $622.7M and Adjusted EBITDA of $99.7M disclosed in the August 10-Q. The number lands after the October 26 agreement to acquire ONRAD for $350 million cash plus stock, a deal that extends RadNet into teleradiology and is the main swing factor for the forward story. With the stock at $76.00 and a market cap near $6 billion, a single adjusted EPS line is a modest update until the full release shows revenue and EBITDA. Watch the complete quarterly release for imaging-center volume growth and Digital Health ARR versus the $105.5M run rate at Q2.
At the time of this announcement, RDNT was trading at $76.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6B. The 52-week trading range was $50.82 to $85.84. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.